• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

The Role of AI in Streamlining Cannabis Dosage Recommendations

by Fred Pennic 12/17/2024 Leave a Comment

The Role of AI in Streamlining Cannabis Dosage Recommendations

The use of medical cannabis is gaining traction for managing a wide range of conditions, from pain to stress. However, determining the right dosage remains a significant challenge.  Factors such as individual metabolism, tolerance levels, and body composition can influence how product potency affects individuals. While you can use these factors to make an educated guess on dosage, pinpointing the ideal potency level often takes experimentation.  However, artificial intelligence
Read More

Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform

by Syed Hamza Sohail 12/16/2024 Leave a Comment

Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform

What You Should Know: -  Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment. - This funding will accelerate the development of Promise Bio's computational platform, which uses epiproteomics and artificial intelligence to predict patient treatment responses and support drug research and development. Revolutionizing Immune-Mediated Disease
Read More

Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO

by Healthcare Executive Hires 12/12/2024 Leave a Comment

Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO

What You Should Know:  - Pleno, an innovative multi-omics diagnostics company, announced it has raised $25M in Series B funding and appointed Dr. Vik Vaz as its new Chief Executive Officer (CEO).  Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the company’s growth strategy. - Dr. Vaz, a seasoned leader with extensive experience in the life sciences and medical technology sectors, will guide
Read More

Capstan Medical Raises $110M to Advance Minimally Invasive Heart Valve Treatment

by Fred Pennic 12/11/2024 Leave a Comment

Capstan Medical Raises $110M to Advance Minimally Invasive Heart Valve Treatment

What You Should Know:  - Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu Galaxy and Intuitive Ventures, and new investment from Gideon Strategic Partners. - Capstan Medical is developing a suite of next-generation heart valve implants and a first-of-its-kind catheter-based robotic delivery platform. Addressing the Global Burden
Read More

Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics

by Syed Hamza Sohail 12/11/2024 Leave a Comment

Nucs AI Secures $3.5 Million to Advance AI-Powered Prostate Cancer Diagnostics

What You Should Know: - Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding. - The company will use the funding to further build out its platform and to support FDA clearance for its technology in the United States.  Nucs AI: Transforming Prostate Cancer Diagnosis and Treatment with Precision Medicine Founded in 2023, Nucs AI is pioneering advancements in
Read More

H1 and CTI Partner for Clinical Trial Optimization

by Syed Hamza Sohail 12/11/2024 Leave a Comment

H1 and CTI Partner for Clinical Trial Optimization

What You Should Know: - H1, on a mission to connect the world to the right doctors, today announced a strategic partnership with CTI Clinical Trial & Consulting Services (CTI), a leading global full-spectrum research service provider.  - Through this partnership, CTI will leverage H1’s Trial Landscape platform to drive data-informed clinical trial planning and execution to enhance strategic feasibility, real-world evidence, and clinical trial execution on a global scale. This
Read More

Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching

by Syed Hamza Sohail 12/09/2024 Leave a Comment

Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company

What You Should Know: - Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.  - The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.  Carta Healthcare and Realyze Intelligence:
Read More

Certis Oncology Launches AI-Powered Chatbot for Cancer Research

by Syed Hamza Sohail 12/09/2024 Leave a Comment

Certis Oncology Solutions Unveils CertisOI Assistant Bringing Chatbot Efficiency to Oncology Research

What You Should Know: - Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research. - This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to provide researchers unparalleled insights
Read More

How Pharma Can Enhance Infusion Clinic Operations and Patient Care

by Patty Trainor, Sr. Director KS&R 12/05/2024 Leave a Comment

How Pharma Can Enhance Infusion Clinic Operations and Patient Care

Infusion Clinics (ICs) face a delicate balancing act. They must strive for operational excellence while simultaneously navigating the realities of competition, patient care challenges, and compliance requirements. It’s a difficult challenge, and as ICs adapt to evolving demands, there’s a growing need for pharmaceutical manufacturers to step up with tailored support.  From streamlining medication access to advocating for policy changes, manufacturers can significantly impact how ICs
Read More

ConcertAI & NeoGenomics Launch CTO-H for Hematology Research

by Syed Hamza Sohail 12/05/2024 Leave a Comment

ConcertAI & NeoGenomics Launch CTO-H for Hematology Research

What You Should Know: - ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization. - CTO-H provides a research data solution that is unprecedented in its scale, longitudinality and biomarker depth. CTO-H is a major outcome of the collaboration jointly announced on Jan. 8, 2024, and the more recent joint research completed and scheduled for
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Go to page 11
  • Go to page 12
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |